August 7, 2007; CHINDEX INTERNATIONAL ANNOUNCES DA VINCI® S" SYSTEM CONTRACT IN HONG KONG; Queen Mary Hospital will be Chindexs Fourth Intuitive Surgical Installation in Greater China
  Home » News » Press Release
Award Ceremony Held in The Great Hall of the People
Chindex the Only Foreign Company to Receive Recognition

BETHESDA, MD (August 5, 2003) - Chindex International, Inc. (Nasdaq:CHDX), the largest independent American distributor of Western healthcare products and services in the People's Republic of China played a key role in the fight against the atypical pneumonia (SARS) epidemic in Beijing earlier this year. Chindex’s contribution to the Beijing municipal effort in the fight against SARS was acknowledged last week in a ceremony at the Great Hall of the People. Chindex’s Beijing United Family Hospital was the only foreign healthcare group to receive recognition.

The ceremony was held on July 25 to honor more than 6,000 healthcare workers from the Beijing area who were instrumental in fighting and ultimately containing the SARS virus. Ms. Roberta Lipson, the President and CEO of Chindex and the Chairman of Chindex’s Beijing United Family Hospital (BJU) was recognized among them. Ms. Lipson, along with Dr. Sarah Borwein and Dr. Alan Mease, led a key working group of physicians and administrators at BJU to coordinate SARS related information and procedures as well as procurement groups at Chindex which supplied critical SARS related emergency products to the Beijing Municipal Government throughout the crisis.

Lipson, a 24-year resident of Beijing, spoke about the SARS experience and the recognition of the Beijing government: “The SARS experience was one of the most demanding periods of my life in China. Daily life and business operations have largely returned to normal now. The epidemic in April, May and June impacted every aspect of our lives. I am very proud to have worked alongside my colleagues at BJU and Chindex to provide critical services to the community in two areas. At BJU we served as the authoritative SARS information center for the international community - early on, we established a 24-hour a day hotline which was used by both expatriate and local Chinese communities. At Chindex we sourced emergency products for the Beijing Ministry of Health on a worldwide basis. While our overall business operations were certainly impacted during that period, the work we were called to do as key players in the Chinese healthcare industry was important and needed. The recognition of our efforts by the Beijing Municipal Government last week was a tribute to everyone at Chindex and BJU who was involved in our tremendous efforts over those weeks. ”

Certain sales of non-SARS related capital equipment were delayed during the SARS period, but a spokesman for the company said that the delayed sales are likely to ship in the current quarter and the company expects a continued increased demand in product areas related to ongoing infection control improvement efforts.

Chindex is a leading American company in healthcare in the Chinese marketplace including Hong Kong. It provides representative and distribution services to a number of major multinational companies in the medical device industry including Siemens AG (diagnostic color ultrasound scanners under the Acuson and Siemens brand names), Becton-Dickinson (including vascular access, infusion and critical care systems), Johnson & Johnson (clinical chemistry analyzers), and Guidant (interventional cardiology products including stents, balloon catheters, and guide wires). Its distribution channels to the retail pharmacy industry in China have been developed through a relationship with a major multinational cosmetics manufacturer. It also provides healthcare services through the operations of its private hospital corporation in China. With twenty-two years of experience, over 600 employees, and operations in the United States, China and Hong Kong, the Company’s strategy is to expand its cross-cultural reach by providing leading edge healthcare technologies, quality products and services to China's professional communities. Further company information may be found at the Company’s websites, and

The statements in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties pertaining to the Company’s (i) performance goals, including successful conclusion of efforts to secure government-backed financing, (ii) future events and earnings, including revenues from the Company’s developmental businesses such as healthcare services, (iii) markets, including growth in demand in China for the Company’s products and services, and (iv) proposed new operations, including expansion of its healthcare services business. Actual results, events and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

Copyright © 2002 Chindex International, Inc. All Rights Reserved